However, it has since been suggested that prostate cancer cells may secrete PD-L1-carrying EVs, leading to the association of anti-PD-L1 drugs to PD-L1 on the EVs, thereby allowing immune escape to occur. The gene discussed is CD274; the disease is Familial prostate cancer.